NCT06090721View on ClinicalTrials.gov

DMT310-009 Topical in the Treatment of Acne Vulgaris

PHASE3CompletedINTERVENTIONAL
Enrollment

520

Participants

Timeline

Start Date

December 8, 2023

Primary Completion Date

March 31, 2025

Study Completion Date

April 30, 2025

Conditions
Acne Vulgaris
Interventions
DRUG

DMT310

Topical Powder

DRUG

Placebo

Placebo Topical Powder

Trial Locations (2)

78759

DermResearch, Austin

94538

Center for Dermatology Clinical Research, Inc., Freemont

Sponsors
All Listed Sponsors
lead

Dermata Therapeutics

INDUSTRY

NCT06090721 - DMT310-009 Topical in the Treatment of Acne Vulgaris | Biotech Hunter | Biotech Hunter